Breathing News and Research

RSS

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema, fluid buildup in the part of the eye responsible for central vision, according to a pilot study by scientists at Johns Hopkins and the National Eye Institute.

18 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Small, frequent doses of caffeine best strategy for staying awake

Caffeine is the world's most widely-used stimulant yet, scientists still do not know exactly how it staves off sleep. Researchers at Brigham and Women's Hospital, Harvard Medical School and other institutions have now discovered that caffeine works by thwarting one of two interacting physiological systems that govern the human sleep-wake cycle.

11 May 2004

New proposals to improve safety of anaesthesia

New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.

10 May 2004

Parents who smoke at home much more likely to have children who suffer from asthma all year round

Children with asthma whose parents smoke at home are twice as likely to have asthma symptoms all year long than children of non-smokers, a new study shows.

4 May 2004

Australia continues to lead the way in asthma management and education

The study reveals that the education and management programs developed and put into action by the National Asthma Council, Asthma Foundations of Australia and other Australian organisations in asthma have proven effective and can be adapted by other countries.

3 May 2004

Treatment for sleep apnea could save 980 lives and $11.1 billion each year

Each year, potentially 980 lives could be saved and $11.1 billion in automobile-accident costs could be avoided if drivers who suffer from a disorder called obstructive sleep apnea were successfully treated with continuous positive airway pressure (CPAP).

1 May 2004

Time matters when treating fungal infections in newborns

A new UCLA study shows that ‘time matters’ when treating fungal infections in neonates and that earlier treatment can mean the difference between life and death.

1 May 2004

British government urging doctors to dissuade unnecessary Caesarean births

Guidelines from the National Institute for Clinical Excellence say doctors should allow a woman to choose how she gives birth. They also say that women must be informed of the risks and benefits of different ways of having a baby.

1 May 2004

Russia's housing conditions linked to high rates of asthma amongst children

Scientists from the University of Birmingham, UK, have worked with the Harvard School of Public Health and universities in Russia to look for the first time at environmental factors causing breathing problems in Russian children.

28 Apr 2004

$11 million for lung injury research

Northwestern University has received an $11 million Program Project Grant (PPG) from the National Institutes of Health to define the mechanisms that cause changes in the alveolar epithelium during lung injury.

27 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

Taiwan raises SARS level to CODE RED

In response to two suspected SARS cases reported in China, Taiwan Department of Health has announced today that starting from April 24, the SARS responsive level will be escalated to level A or Code Red, the highest state of alert.

24 Apr 2004

FDA approves Advair Diskus® for children with asthma

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) approved the use of Advair 100/50 in children four years to eleven years of age with asthma who are symptomatic on inhaled corticosteroid therapy alone.

22 Apr 2004

Second-hand smoke scars and affects healing

Researchers at the University of California, Riverside have found that breathing “second-hand” smoke reduces the speed at which wounds heal, leading to greater levels of scarring.

17 Apr 2004

Tibetan yoga helps cancer and insomnia

The first study to look at the use of Tibetan yoga by cancer patients found the combination of movement and meditation led to a significant sleep benefit, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Apr 2004

Houston blows poor air not just hot air

A study by a Texas A&M University researcher shows that Houston has wild fluctuations of air pollution – far above acceptable national standards – and these could pose a serious health risk to the city's inhabitants unless controls are quickly started.

14 Apr 2004

Mercy Hospital opens new cardiovascular catheterization laboratory

The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.

13 Apr 2004

Breast-feeding may protect against SIDS

Breast-fed babies arouse more readily from deep sleep, Monash researchers have found, in a discovery that could help reduce deaths due to Sudden Infant Death Syndrome (SIDS).

7 Apr 2004

University of Florida researchers have used a common gel to successfully deliver gene therapy to the diaphragm

The technique, described in the current issue of Molecular Therapy, could eventually lead to a method to correct genetic conditions in humans that cause diaphragm weakness and respiratory failure -- a leading cause of death in tens of thousands of patients with forms of muscular dystrophy, including Pompe’s disease. Thousands of Americans with muscle-weakening diseases are placed on ventilators each year, according to the Muscular Dystrophy Association.

7 Apr 2004